title: [Drug-induced readjustment of therapy-resistant hypertension].
abstract: By a combined vasodilator-[diisopropylamine (disostat), dihydralazine (depressan)] furosemide- (furesis-) infusion therapy was tried to achieve a new stabilisation of the blood pressure of therapy-refractory patients with hypertension. Propranolol (Obsidan) was additionally administered for the suppression of a sympathetic counter-regulation. On 3 patients is demonstrated how by a ten days' intensive decrease of the blood pressure and decrease of the extracellular fluid volume the therapy resistance may be interrupted and a repeated response to an oral antihypertensive standard therapy may be achieved.
mesh_terms: D004078:Dihydralazine / Q000627:therapeutic use; D004338:Drug Combinations; D004351:Drug Resistance; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D011437:Propylamines; D005665:Furosemide; D011433:Propranolol; D004078:Dihydralazine
vernacular_title: Pharmakainduzierte Neueinstellung der therapieresistenten Hypertonie.